Rocuronium bromide 98%

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer [HK1] of small volume liquid parenteral products, to become one of the largest and fastest growing generic injectables manufacturing companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the pharmaceutical research and development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We have a professional management team and one of our Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major.